LEVONEST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levonest, and when can generic versions of Levonest launch?
Levonest is a drug marketed by Novast Labs Ltd and is included in one NDA.
The generic ingredient in LEVONEST is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVONEST?
- What are the global sales for LEVONEST?
- What is Average Wholesale Price for LEVONEST?
Summary for LEVONEST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 277 |
| DailyMed Link: | LEVONEST at DailyMed |
US Patents and Regulatory Information for LEVONEST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs Ltd | LEVONEST | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 090719-001 | Dec 29, 2010 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
